A step backwards in the fight against global vaccine inequities

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-12-31

Type Journal Article Author Ernest Aryeetey Author Eivind Engebretsen Author Åse Gornitzka Author Peter Maassen Author Svein Stølen URL https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32596-4/abstract Publication The Lancet ISSN 0140-6736, 1474-547X Date 09/12/2020 Extra Publisher: Elsevier PMID: 33308424 Journal Abbr The Lancet DOI 10.1016/S0140-6736(20)32596-4 Library Catalog www.thelancet.com Language English Abstract The news that an effective vaccine against severe acute respiratory syndrome coronavirus 2 will be introduced imminently was welcomed with great enthusiasm worldwide. The consensus is that access to vaccines for low-income countries is a global responsibility.1 To make sure that all countries and their citizens will have equal access to a vaccine, Eswatini, India, Kenya, and South Africa proposed a waiver2 from certain provisions of the Agreement on Trade-Related Aspects of Intellectual Property Rights by the World Trade Organization.